1. Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. (31 from 343 patents)

2. Istituto Nazionale Per Lo Studio E La Cura Dei Tumori (4 from 14 patents)

3. Sigma-Tau Research Switzerland S.a. (3 from 3 patents)

4. Biogem S.c. a R.l. (3 from 3 patents)

5. Instituto Nazionale Per Lo Studio E La Cura Dei Tumori (2 from 3 patents)

6. Sigma-Tau Farmaceutiche Riunite, S.p.a. (1 from 3 patents)

7. Istituo Nazionale Per Lo Studio E La Cura Dei Tumori (1 from 1 patent)

8. Novartis Ag (3,933 patents)

9. Alfasigma S.p.a. (23 patents)

10. Novartis Pharma Gmbh (8 patents)

11. Maria Ornella Tinti (0 patent)

12. Luciana Critelli (0 patent)

13. Mose Santaniello (0 patent)

14. Claudio Pisano (0 patent)

15. Giovanni Salvatori (0 patent)

1. 11819484 - Retinoid derivatives with antitumor activity

2. 11364216 - Retinoid derivatives with antitumor activity

3. 10905668 - Retinoid derivatives with antitumor activity

4. 9302998 - Aryl triazole compounds with antitumoural activity

5. 9023861 - Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents

6. 8975248 - Combinations of therapeutic agents for treating cancer

7. 8927533 - Thio derivatives bearing lactams as potent HDAC inhibitors and their uses as medicaments

8. 8853233 - Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives

9. 8829021 - Treatment of pediatric tumors

10. 8530517 - Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties

11. 8383616 - Aryl isoxazole compounds with antitumoural activities

12. 8222231 - Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect

13. 8101793 - Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities

14. 8067555 - Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect

15. 8053460 - Indole derivatives having antitumor activity